{
    "clinical_study": {
        "@rank": "161250", 
        "arm_group": [
            {
                "arm_group_label": "Probiotic tablet", 
                "arm_group_type": "Active Comparator", 
                "description": "Lactobacillus rhamnosus 8-9 x 10 -9 2 x 2 3 weeks"
            }, 
            {
                "arm_group_label": "Placebo tablet", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Chrystalline celluloce 2 x 2, 3 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of regular consumption of probiotic\n      tablets in preventing illnesses in Finnish healthy adults attending military service."
        }, 
        "brief_title": "Probiotics and Infections in Conscripts in Military Service", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Respiratory Tract Infections", 
            "Gastrointestinal Diseases", 
            "Asthma Exacerbations"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gastrointestinal Diseases", 
                "Digestive System Diseases", 
                "Respiratory Tract Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy adults attending military service in July 2012 and healthy adults attending\n             reserve office school in October 2012\n\n        Exclusion Criteria:\n\n          -  Regular use of oral corticosteroids\n\n          -  Regular consumption (over 3 times a week) of probiotic bacteria containing products 3\n             weeks before intervention"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01651195", 
            "org_study_id": "189/13/03/00/11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Probiotic tablet", 
                "intervention_name": "Probiotic", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo tablet", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hamina", 
                        "country": "Finland"
                    }, 
                    "name": "The Finnish Defence Forces"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Upinniemi", 
                        "country": "Finland"
                    }, 
                    "name": "The Finnish Defence Forces"
                }
            }
        ], 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Lactobacillus Rhamnosus GG in the Middle Ear After Randomized, Double-blind, Placebo-controlled Oral Administration", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Finland: Ethics Committee"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The primary outcome measure is the recovery of Lactobacillus rhamnosus GG in the middle ear effusion and adenoid tonsil", 
            "safety_issue": "No", 
            "time_frame": "May 2009"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01651195"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Helsinki University Central Hospital", 
            "investigator_full_name": "Anne pitk\u00e4ranta", 
            "investigator_title": "Professor/Chief Physician at Hospital District of Helsinki and Uusimaa", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Helsinki University Central Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Helsinki University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Finnish Defense Forces", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Institute for Health and Welfare, Finland", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Helsinki University Central Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}